Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Talaporfin MeSH Supplementary Concept Data 2026


MeSH Supplementary
Talaporfin
Unique ID
C053434
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C053434
Entry Term(s)
Laserphyrin
N-aspartyl chlorin e6
N-aspartylchlorin e6
NPe6
mono-L-aspartyl chlorin e6
monoaspartyl chlorin e6
talaporfin sodium
Pharm Action
Antineoplastic Agents
Photosensitizing Agents
Registry Numbers
P4ROX5ELT2
L63605PZ70
0
Related Numbers
110230-98-3
220201-34-3
L63605PZ70
CAS Type 1 Name
L-Aspartic acid, N-(3-(18-carboxy-20-(carboxymethyl)-8- ethenyl-13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-21H,23H- porphin-2-yl)-1-oxopropyl)-, (2S-trans)-
Heading Mapped to
*Porphyrins
Frequency
188
Note
effective tumor localizer that brings about the selective degradation of tumor tissue following light exposure; structure given in first source
Source
Cancer Res 1987;47(17):4681
Date Introduced
1987/09/28
Last Updated
2016/08/17
Talaporfin Preferred
talaporfin sodium Narrower
Laserphyrin Narrower
page delivered in 0.007s